article thumbnail

Pharmapack Europe 2025: Eco barrier packaging to launch

European Pharmaceutical Review

LOG Pharma Primary Packaging is set to present its new barrier eco line at Pharmapack Europe 2025. LOGs barrier packaging solutions are designed to prolong shelf life and protect innovative and generic drugs from the exposure to moisture and/or oxygen, the company explained on its website.

Packaging 105
article thumbnail

DHL Group commits €2 billion to expand life sciences and healthcare logistics by 2030

Express Pharma

This investment is part of the Groups Strategy 2030 and is aimed at enabling healthcare customers to expand operations, support innovation, and deliver patient services across key global regions. The Group projects an additional 5 billion in incremental revenue by 2030.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Morepen Laboratories expands its domestic portfolio

Express Pharma

The product is offered in a 4×14 patient-compliant pack with day/night markers and matte foil packaging. per cent dissolution rate, anti-counterfeit Holosec packaging, and competitive pricing at 39.9 per cent dissolution rate, anti-counterfeit Holosec packaging, and competitive pricing at 39.9 The company notes its 98.23

article thumbnail

Anti-Counterfeit Packaging Market Estimated to Reach Nearly $436 Million by 2030

Pharmaceutical Commerce

Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.

article thumbnail

Pharmapack Europe to launch two new zones in 2024

European Pharmaceutical Review

In 2024, Pharmapack Europe, the two-day exhibition and conference for pharma’s drug delivery and packaging industry will introduce two brand new zones to the flagship event. Bio packaging zone . Pharmapack’s bio packaging zone builds on its long history of being at the forefront of innovations in biological drug delivery.

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. We have committed to reduce our scope 1 and 2 GHG emissions by 42 per cent (absolute) by the end of 2030 (from a 2021 basis).

Dosage 104
article thumbnail

Strengthening our presence within APAC through increased penetration is a key focus

Express Pharma

We also see a growing emphasis on sustainable practices in manufacturing and packaging, aligning with global trends in reducing carbon footprint and waste. In addition, the nutra market boom in APAC that began during the COVID-19 pandemic continues to accelerate looking for green-label, plant-based capsules for encapsulation.

Labelling 104